I. Mcquaker

发表

Haemopoietic Stem Cell Transplantation

I. McQuaker, I. Franklin, I. Mcquaker, 2009 .

Complete molecular responses are achieved after reduced intensity stem cell transplantation and donor lymphocyte infusion in chronic myeloid leukemia.

C. Crawley, M. Copland, T. Holyoake, 2008, Blood.

TNF Polymorphisms Independently Predict Outcome in Patients with B-Cell Non-Hodgkin’s Lymphoma

A. Elkordy, I. McQuaker, T. Holyoake, 2009 .

Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate‐dose cyclophosphamide

N. Russell, A. Haynes, I. McQuaker, 1997, British journal of haematology.

Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit.

A. Hunter, N. Russell, A. Haynes, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mobilisation of peripheral blood stem cells with IVE and G-CSF improves CD34+ cell yields and engraftment in patients with non-Hodgkin’s lymphomas and Hodgkin’s disease

N. Russell, I. McQuaker, A. Haynes, 1999, Bone Marrow Transplantation.

Engraftment and molecular monitoring of CD34+ peripheral-blood stem-cell transplants for follicular lymphoma: a pilot study.

N. Russell, J. Davis, A. Haynes, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High Dose Ifosfamide in Combination with Etoposide and Epirubicin Followed by Autologous Stem Cell Transplantation in the Treatment of Relapsecd/Refractory Hodgkin's Disease: a Report on Toxicity and Efficacy On behalf of the Scotland and Newcastle Lymphoma Group

N. Russell, N. Russell, B. Angus, 2000, Leukemia & lymphoma.

The clinical features and outcome of 2009 H1N1 influenza infection in allo-SCT patients: a British Society of Blood and Marrow Transplantation study

S. Nagra, G. Cook, M. Gilleece, 2012, Bone Marrow Transplantation.

Coil embolization of cerebral aneurysms in patients with sickling disorders

T. Jaspan, G. Dolan, N. McConachie, 1999, British journal of haematology.

A comparison of two different systems for CD34+ selection of autologous or allogeneic PBSC collections.

C J Stainer, G Miflin, S Anderson, 1998, Journal of hematotherapy.

Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study.

James Robinson, N. Russell, S. Mackinnon, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

(2019). Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study. Biology of Blood and Marrow Transplantation , 25 (3), 443-450.

N. Russell, S. Mackinnon, J. Madrigal, 2019 .

Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML

E. Tholouli, N. Russell, J. Byrne, 2020, Bone Marrow Transplantation.

Dose escalation therapy in previously untreated patients with multiple myeloma following Z‐Dex induction treatment

G. Cook, A. Clark, K. Douglas, 2002, British journal of haematology.

Ideal body weight correlates better with engraftment after PBSC autograft than actual body weight, but is under-estimated in myeloma patients possibly due to disease-related height loss

P. MacLean, A. Clark, K. Douglas, 2007, Bone Marrow Transplantation.

Fatal peripheral neuropathy following FLA chemotherapy.

T. Holyoake, A. Parker, I. McQuaker, 2004, Clinical and laboratory haematology.

Response to thalidomide in chemotherapy‐resistant mantle cell lymphoma: a case report

R. Jackson, A. Parker, I. McQuaker, 2002, British journal of haematology.